Assignee
MESOBLAST INT SARL
CH·29 granted patents·38 pending applications·143 citations·filing 2013–2025
Top patents by PatentIndex Score
67 records- 0197US10960025B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2020·Granted Mar 30, 2021·5 cites·14 claims
- 0297US10828334B1Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2020·Granted Nov 10, 2020·5 cites·30 claims
- 0397US10716814B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2018·Granted Jul 21, 2020·10 cites·22 claims
- 0496US10729727B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2018·Granted Aug 4, 2020·7 cites·23 claims
- 0596US10550369B2Enhanced MSC preparationMESOBLAST INT SARL·Filed 2018·Granted Feb 4, 2020·19 cites·20 claims
- 0695US11389484B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2018·Granted Jul 19, 2022·4 cites·19 claims
- 0795US10668101B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2013·Granted Jun 2, 2020·10 cites·17 claims
- 0895US9963678B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2015·Granted May 8, 2018·17 cites·11 claims
- 0994US9943547B2Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2013·Granted Apr 17, 2018·14 cites·21 claims
- 1094US9828586B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2013·Granted Nov 28, 2017·20 cites·19 claims
- 1193US11821004B2Mesenchymal stem cells expressing TNF-α receptorsMESOBLAST INT SARL·Filed 2020·Granted Nov 21, 2023·3 cites·13 claims
- 1293US10400218B2Stem cell compositionMESOBLAST INT SARL·Filed 2015·Granted Sep 3, 2019·11 cites·8 claims
- 1391US2026035666A1Enhanced msc preparationsMESOBLAST INT SARL·Filed 2025·Application pending·0 cites
- 1489US12115194B2Prevention of progressive heart failureMESOBLAST INT SARL·Filed 2022·Granted Oct 15, 2024·1 cites·13 claims
- 1588US10624930B2Treatment of immune disordersMESOBLAST INT SARL·Filed 2015·Granted Apr 21, 2020·5 cites·19 claims
- 1686US11491188B2Prevention of progressive heart failureMESOBLAST INT SARL·Filed 2015·Granted Nov 8, 2022·3 cites·16 claims
- 1785US12410405B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2023·Granted Sep 9, 2025·0 cites·16 claims
- 1885US11708560B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2019·Granted Jul 25, 2023·2 cites·7 claims
- 1985US2025129337A1Cell culture method for mesenchymal stem cellsMESOBLAST INT SARL·Filed 2024·Application pending·0 cites
- 2084US2023076630A1Mesenchymal stem cells and uses thereforMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 2184US2024301356A1Mesenchymal stem cells expressing tnf-alpha receptorsMESOBLAST INT SARL·Filed 2023·Application pending·0 cites
- 2283US12215352B2Cell culture method for mesenchymal stem cellsMESOBLAST INT SARL·Filed 2023·Granted Feb 4, 2025·0 cites·10 claims
- 2382US12257270B2Treatment of immune disordersMESOBLAST INT SARL·Filed 2022·Granted Mar 25, 2025·0 cites·10 claims
- 2481US9814580B2Joint repair using mesenchymal stem cellsMESOBLAST INT SARL·Filed 2015·Granted Nov 14, 2017·3 cites·22 claims
- 2578US11795435B2Potency assayMESOBLAST INT SARL·Filed 2016·Granted Oct 24, 2023·2 cites·11 claims
- 2678US2025064858A1Prevention of progressive heart failureMESOBLAST INT SARL·Filed 2024·Application pending·0 cites
- 2777US12303536B2Method for treating heart failureMESOBLAST INT SARL·Filed 2023·Granted May 20, 2025·0 cites·14 claims
- 2877US11242506B2Methods and apparatus for separating cells from microcarriersMESOBLAST INT SARL·Filed 2016·Granted Feb 8, 2022·2 cites·10 claims
- 2977US2023030428A1Stem cell compositionMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 3075US11312941B2Stem cell compositionMESOBLAST INT SARL·Filed 2019·Granted Apr 26, 2022·0 cites·7 claims
- 3175US2023089901A1Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositionsMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 3274US2025312379A1Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositionsMESOBLAST INT SARL·Filed 2025·Application pending·0 cites
- 3374US2024076621A1Potency assayMESOBLAST INT SARL·Filed 2023·Application pending·0 cites
- 3472US11685899B2Cell culture method for mesenchymal stem cellsMESOBLAST INT SARL·Filed 2019·Granted Jun 27, 2023·0 cites·11 claims
- 3572US11406669B2Treatment of immune disordersMESOBLAST INT SARL·Filed 2020·Granted Aug 9, 2022·0 cites·20 claims
- 3672US2025136944A1Stem cell compositionMESOBLAST INT SARL·Filed 2025·Application pending·0 cites
- 3772US2025319134A1Treatment of immune disordersMESOBLAST INT SARL·Filed 2025·Application pending·0 cites
- 3870US2025249043A1Method for treating heart failureMESOBLAST INT SARL·Filed 2025·Application pending·0 cites
- 3969US2026069635A1Mesenchymal progenitor cells for enhancing partial reprogramming of target cellsMESOBLAST INT SARL·Filed 2023·Application pending·0 cites
- 4069US2020197444A1Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositionsMESOBLAST INT SARL·Filed 2019·Application pending·0 cites
- 4167US2024207323A1Method for treating acute respiratory distress syndrome (ards) using mesenchymal lineage precursor or stem cellsMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 4267US2024197787A1Method for treating acute respiratory distress syndrome (ards) in specific patients using mesenchymal lineage precursor or stem cellsMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 4362US2018087032A1Mesenchymal stem cells expressing tnf-alpha receptorsMESOBLAST INT SARL·Filed 2017·Application pending·0 cites
- 4462US2025032552A1Method of treating severe graft versus host diseaseMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 4562US2025319428A1High flow filter and method of useMESOBLAST INT SARL·Filed 2023·Application pending·0 cites
- 4660US2023220349A13d culture of mesenchymal lineage precursor or stem cellsMESOBLAST INT SARL·Filed 2021·Application pending·0 cites
- 4759US2023293590A1Cellular compositions and methods of treatmentMESOBLAST INT SARL·Filed 2021·Application pending·0 cites
- 4859US2025090589A1Method of treating progressive heart failure in subjects at high risk of poor outcomesMESOBLAST INT SARL·Filed 2022·Application pending·0 cites
- 4959US2023097931A1Method for treating chronic graft versus host diseaseMESOBLAST INT SARL·Filed 2021·Application pending·0 cites
- 5058US2018037867A1Cell culture method for mesenchymal stem cellsMESOBLAST INT SARL·Filed 2016·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MESOBLAST INT SARL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →